Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -43.60 | 12.44 |
| PEG Ratio (TTM) | 0.05 | 4.23 |
| P/S Ratio (TTM) | 0.89 | 1.38 |
| P/B Ratio (TTM) | 1.39 | -10.78 |
| P/FCF Ratio (TTM) | 16.29 | 18.24 |
| Price to 5YR AVG Earnings Ratio | 37.27 | 19.29 |
| Price to 5YR AVG FCF Ratio | 23.24 | 23.57 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.80% | 5.28% |
| ROE (TTM) | -3.11% | -83.47% |
| Net Profit Margin (TTM) | -2.03% | 1.94% |
| ROIC 5YR AVG | 7.44% | 16.73% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -340.76% | 1,198.47% | 696.48% |
| Revenue | 3.49% | 8.19% | 9.35% |
| Net Income | -343.08% | 1,787.90% | 1,054.61% |
| Cash Flow | 1.76% | 5.16% | 36.57% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.80 | 1.35 |
| Quick Ratio (TTM) | 1.66 | 1.24 |
| D/E Ratio (TTM) | 1.68 | -5.34 |
| Interest Coverage (TTM) | 1.80 | 5.93 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 0.83 | 2.90 |
| LTL to 5YR AVG FCF | 19.93 | 7.86 |
| Shares Outstanding Growth 5YR AVG | 22.72% | -0.29% |